Non-Nucleoside Agonists of the Adenosine Receptors: An Overview.
adenosine receptor agonists
adenosine receptors
drug discovery
ligand–target interaction
non-nucleoside agonists
purinergic receptors
pyridine derivatives
pyrimidine derivatives
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
08 Oct 2019
08 Oct 2019
Historique:
received:
09
09
2019
revised:
03
10
2019
accepted:
05
10
2019
entrez:
11
10
2019
pubmed:
11
10
2019
medline:
11
10
2019
Statut:
epublish
Résumé
Potent and selective adenosine receptor (AR) agonists are of pharmacological interest for the treatment of a wide range of diseases and conditions. Among these derivatives, nucleoside-based agonists represent the great majority of molecules developed and reported to date. However, the limited availability of compounds selective for a specific AR subtype (i.e., A
Identifiants
pubmed: 31597388
pii: ph12040150
doi: 10.3390/ph12040150
pmc: PMC6958362
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : undefined <span style="color:gray;font-size:10px;">undefined</span>
ID : 2015E8EMCM_008
Organisme : Italian Ministry of Research
ID : 2015E8EMCM_008
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Biochemistry. 2013 Jan 29;52(4):726-40
pubmed: 23286920
Bioorg Med Chem. 2008 Mar 15;16(6):2741-52
pubmed: 18258439
JAMA. 2019 Jun 4;321(21):2101-2112
pubmed: 31162568
Biochem Pharmacol. 2017 Jul 1;135:79-89
pubmed: 28344125
Physiol Rev. 2018 Jul 1;98(3):1591-1625
pubmed: 29848236
J Med Chem. 1998 Aug 13;41(17):3174-85
pubmed: 9703463
J Clin Pharmacol. 2017 Apr;57(4):440-451
pubmed: 27624622
Expert Opin Investig Drugs. 2019 Jan;28(1):51-71
pubmed: 30523722
Medchemcomm. 2017 Nov 9;9(1):81-86
pubmed: 30108902
J Med Chem. 2007 May 31;50(11):2732-6
pubmed: 17469811
Eur J Med Chem. 2015 Aug 28;101:681-91
pubmed: 26210506
Handb Exp Pharmacol. 2017;243:177-203
pubmed: 27770217
Pharmacol Ther. 2013 Aug;139(2):157-88
pubmed: 23588157
Curr Top Med Chem. 2010;10(10):993-1018
pubmed: 20370656
J Med Chem. 2009 Dec 10;52(23):7897-900
pubmed: 19839592
J Med Chem. 2016 Jun 23;59(12):5922-8
pubmed: 27227326
J Med Chem. 1994 May 27;37(11):1720-6
pubmed: 8201607
Lancet. 2019 Mar 9;393(10175):1034-1044
pubmed: 30860029
Pharmacol Rev. 2001 Dec;53(4):527-52
pubmed: 11734617
Handb Exp Pharmacol. 2009;(193):443-70
pubmed: 19639291
Org Lett. 2006 Mar 2;8(5):899-902
pubmed: 16494469
Science. 2011 Apr 15;332(6027):322-7
pubmed: 21393508
Oxid Med Cell Longev. 2015;2015:585297
pubmed: 26161239
Curr Pharm Des. 2019;25(25):2697-2715
pubmed: 31333094
PLoS One. 2012;7(7):e40584
pubmed: 22848385
Pharmacol Ther. 2013 Oct;140(1):92-111
pubmed: 23764371
Mol Inform. 2016 Sep;35(8-9):403-13
pubmed: 27546044
Front Cell Neurosci. 2019 Mar 28;13:124
pubmed: 30983976
J Pharmacol Exp Ther. 2014 Jun;349(3):427-36
pubmed: 24633424
Mol Pharmacol. 2015 Jun;87(6):907-15
pubmed: 25762024
Diabetes. 2014 Mar;63(3):850-66
pubmed: 24194503
ChemMedChem. 2017 May 22;12(10):728-737
pubmed: 28488817
J Med Chem. 2004 Jul 15;47(15):3707-9
pubmed: 15239649
Chem Biol Drug Des. 2016 Nov;88(5):724-729
pubmed: 27282729
Eur J Heart Fail. 2019 Nov;21(11):1426-1433
pubmed: 31523892
Farmaco. 2003 Mar;58(3):193-204
pubmed: 12620415
J Med Chem. 2019 Aug 8;62(15):6894-6912
pubmed: 31306001
Clin Res Cardiol. 2012 Jul;101(7):585-91
pubmed: 22370739
Biochem Pharmacol. 2010 Oct 15;80(8):1180-9
pubmed: 20599769
Handb Exp Pharmacol. 2009;(193):25-58
pubmed: 19639278
J Med Chem. 2014 Apr 24;57(8):3213-22
pubmed: 24669958
Front Pharmacol. 2018 Mar 14;9:212
pubmed: 29593540
Br J Pharmacol. 2006 Mar;147(5):533-41
pubmed: 16444290
Adv Pharmacol. 2011;61:95-114
pubmed: 21586357
Purinergic Signal. 2012 Feb;8(Suppl 1):91-9
pubmed: 22081230
Circ Heart Fail. 2013 May;6(3):563-71
pubmed: 23564604
Purinergic Signal. 2009 Mar;5(1):3-19
pubmed: 19184536
Eur J Med Chem. 2018 Apr 25;150:127-139
pubmed: 29525433
Curr Top Med Chem. 2003;3(4):427-43
pubmed: 12570760
In Silico Pharmacol. 2013 Dec 20;1:24
pubmed: 25505666
J Surg Res. 2018 Dec;232:442-449
pubmed: 30463755
Biochim Biophys Acta. 2011 May;1808(5):1290-308
pubmed: 21185259
Prog Med Chem. 2009;47:163-201
pubmed: 19328291
J Am Chem Soc. 2013 Jun 12;135(23):8749-59
pubmed: 23678995
Nat Rev Drug Discov. 2013 Apr;12(4):265-86
pubmed: 23535933
J Immunol. 2015 Aug 15;195(4):1815-24
pubmed: 26188061
J Chem Inf Model. 2015 Mar 23;55(3):550-63
pubmed: 25625646
J Med Chem. 1992 Jun 26;35(13):2363-8
pubmed: 1619615
Biochem Pharmacol. 2016 Jan 1;99:101-12
pubmed: 26581123
Tetrahedron Lett. 2012 Sep 5;53(36):4870-4872
pubmed: 23002309
Bioorg Med Chem. 2009 Apr 1;17(7):2812-22
pubmed: 19282184
Nat Rev Drug Discov. 2006 Mar;5(3):247-64
pubmed: 16518376
PLoS One. 2011 Mar 28;6(3):e18048
pubmed: 21464936
PLoS One. 2014 Jun 03;9(6):e98775
pubmed: 24892847
J Pharmacol Exp Ther. 2017 Sep;362(3):424-430
pubmed: 28652388
Nature. 2018 Jun;558(7711):559-563
pubmed: 29925945
Curr Top Med Chem. 2011;11(8):1034-46
pubmed: 21401497
Circulation. 2007 Mar 27;115(12):1581-90
pubmed: 17353435
Biochem Pharmacol. 2013 May 1;85(9):1317-29
pubmed: 23500543
J Med Chem. 2008 Mar 27;51(6):1764-70
pubmed: 18269230
Nature. 2011 May 18;474(7352):521-5
pubmed: 21593763
J Med Chem. 2004 Dec 16;47(26):6529-40
pubmed: 15588088
Pharmacol Rev. 2011 Mar;63(1):1-34
pubmed: 21303899
J Med Chem. 1995 Apr 28;38(9):1462-72
pubmed: 7739005
J Med Chem. 2005 Mar 24;48(6):2045-53
pubmed: 15771447
J Med Chem. 2018 Nov 21;61(22):9966-9975
pubmed: 30359014
Biochem Pharmacol. 2011 Aug 15;82(4):389-99
pubmed: 21620804
Mol Pharmacol. 2012 Mar;81(3):475-87
pubmed: 22188926
Bioorg Chem. 2019 Nov;92:103183
pubmed: 31446240
J Cell Physiol. 2011 Jan;226(1):46-51
pubmed: 20717958